Rx · PZN 00772197, 00772205, 02918251
LEVODOPA-Carbidopa-neuraxpharm 100-25 mg prolonged-release tablets
German trade nameLEVODOPA Carbidopa-neuraxpharm 100-25 mg Retard Tabletten
Consistently available
9.6out of 10
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
LEVODOPA-Carbidopa-neuraxpharm 100-25 mg prolonged-release tablets is consistently available through wholesale. We are happy to review your purchase price and advise you on it.
Review purchasing termsLEVODOPA-Carbidopa-neuraxpharm 100-25 mg prolonged-release tablets contains the active ingredient Levodopa and decarboxylase inhibitor (German Levodopa und Decarboxylasehemmer*) and comes as Prolonged-release tablets. 3 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 9.5 to 9.6 out of 10. The best-available pack was consistently available.
Pack sizes · 3 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 00772205 | 9.3 | 9.6 | ~ €21 |
| 02918251 | 9.4 | 9.6 | ~ €42 |
| 00772197 | 9.2 | 9.5 | ~ €13 |
We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.
Get in touch